General Information

Date June 22-24, 2017
Venue Royton Sapporo
(Nishi 11-Chome, Kita 1 Jo, Chuo-ku, Sapporo, Hokkaido 060-0001, Japan)
Phone: +81-11-271-2711
  • Scientific Oral Sessions:2F Empress Hall
  • Poster Session:2F Crystal A & B
  • Banquet: 2F Regent Hall
Theme Advances in Tumor Immunology and Immunotherapy
“From Basic Research to Precision Medicine”
「腫瘍免疫学と免疫療法の進步: 基礎研究から最適化医療へ」
Organizer The Sapporo Cancer Seminar Foundation

Toshihiko Torigoe, MD, PhD, Sapporo Medical University, Japan
Tsukasa Seya, MD, PhD, Hokkaido University, Japan
Yutaka Kawakami, MD, PhD, Keio University, Japan

Akinori Takaoka, MD, PhD, Hokkaido University, Japan
Heiichiro Udono, MD, PhD, Okayama University, Japan
Hiroaki Ikeda, MD, PhD, Nagasaki University, Japan
Hiroya Kobayashi, MD, PhD, Asahikawa Medical University, Japan
Hiroyoshi Nishikawa, MD, PhD, Nagoya University, Japan
Kazuhiro Kakimi, MD, PhD, The University of Tokyo Hospital, Japan
Ken-ichiro Seino, MD, PhD, Hokkaido University, Japan
Koji Tamada, MD, PhD, Yamaguchi University, Japan
Shigehisa Kitano, MD, PhD, National Cancer Center Hospital, Japan
Yasuharu Nishimura, MD, PhD, Kumamoto University, Japan
Yuji Heike, MD, PhD, St. Luke's International Hospital, Japan

Tomohide Tsukahara, MD, PhD, Sapporo Medical University, Japan
Tomonobu Fujita, PhD, Keio University, Japan
Yoshihiko Hirohashi, MD, PhD, Sapporo Medical University, Japan

(alphabetical order)


The Uehara Memorial Foundation
Sapporo Medical University
Sumitomo Dainippon Pharma Co., Ltd.
Ono Pharmaceutical Co., Ltd.
AstraZeneca K.K.

(as of June 5, 2017)

Language Official language is English.
Secretariat for the 36th SCS Department of Pathology 1, Sapporo Medical University
S-1, W-17, Chuo-ku, Sapporo 060-8556, Japan
TEL & FAX: +81-11-643-2310